COST
54
6
WM
74
6
BF.B
50
3
EXC
63
2
XRAY
40
17
EL
52
-4
BIIB
50
4
CMCSA
41
2
VRTX
69
4
AZO
56
4
SCHW
50
-2
MET
32
-11
CF
38
2
UAL
51
-9
VIX
52
5
CCL
61
-6
CVX
55
6
DRI
63
2
AAP
30
7
NEM
67
2
COST
54
6
WM
74
6
BF.B
50
3
EXC
63
2
XRAY
40
17
EL
52
-4
BIIB
50
4
CMCSA
41
2
VRTX
69
4
AZO
56
4
SCHW
50
-2
MET
32
-11
CF
38
2
UAL
51
-9
VIX
52
5
CCL
61
-6
CVX
55
6
DRI
63
2
AAP
30
7
NEM
67
2
Financhill
Back

Quince Therapeutics, Inc. 10K Form

Sell
16

QNCX
Quince Therapeutics, Inc.

Last Price:
$0.10
Seasonality Move:
-1.12%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive QNCX News And Ratings

See the #1 stock for the next 7 days that we like better than QNCX

QNCX Financial Statistics

Sales & Book Value

Annual Sales: $0
Cash Flow: $-10M
Price / Cash Flow: 0
Annual Sales: $0.02
Price / Book: 6.61

Profitability

EPS (TTM): -1.21890
Net Income (TTM): $-57M
Gross Margin: $-186K
Return on Equity: -267.62%
Return on Assets: -48.55%

Quince Therapeutics, Inc. Earnings Forecast

Key Quince Therapeutics, Inc. Financial Ratios

  • Per Share Earnings over the last 8 years have been positive in 2 years.

Quince Therapeutics, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: QNCX
Website: quincetx.com

Debt

Debt-to-Equity Ratio: 16.99
Current Ratio: 1.12
Quick Ratio: 1.01

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

QNCX Technical Analysis vs Fundamental Analysis

Sell
16
Quince Therapeutics, Inc. (QNCX) is a Sell

Is Quince Therapeutics, Inc. a Buy or a Sell?